42%的患者肿瘤缩小或消失！国内外TCR-T细胞疗法大展身手
CN-Healthcare,
2025年1月2日，星汉德生物宣布，国家药品监督管理局药品审评中心（CDE）已批准其全新一代人乳头瘤病毒（HPV）特异性T细胞受体（TCR）工程化T细胞治疗产品 2025年1月2日，星汉德生物宣布，国家药品监督管理局药品审评中心（CDE）已批准其全新一代人乳…
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer
Overview of attention for article published in Clinical Cancer Research, November 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Mentioned by
- news
- 1 news outlet
- 15 X users
- patent
- 1 patent
- 1 Redditor
- bluesky
- 1 Bluesky user
Readers on
- mendeley
- 20 Mendeley